Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease

被引:130
作者
Buchheit, Kathleen M. [1 ,3 ]
Cahill, Katherine N. [1 ,3 ]
Katz, Howard R. [1 ,3 ]
Murphy, Katherine C. [3 ]
Feng, Chunli [3 ]
Lee-Sarwar, Kathleen [1 ]
Lai, Juying [3 ]
Bhattacharyya, Neil [2 ,4 ]
Israel, Elliot [1 ,5 ]
Boyce, Joshua A. [1 ,3 ]
Laidlaw, Tanya M. [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Otolaryngol, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Div Pulm Med, 75 Francis St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Aspirin-exacerbated respiratory disease; Samter triad; nasal polyps; thymic stromal lymphopoietin; prostaglandin D-2; cysteinyl leukotrienes; innate immunity; mast cells; eosinophils; INNATE LYMPHOID-CELLS; HUMAN EPITHELIAL-CELLS; MAST-CELL; EOSINOPHILIC INFLAMMATION; CYSTEINYL LEUKOTRIENES; CHRONIC RHINOSINUSITIS; ALLERGIC INFLAMMATION; CYTOKINE PRODUCTION; ASTHMATIC AIRWAYS; EXPRESSION;
D O I
10.1016/j.jaci.2015.10.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Prostaglandin (PG) D-2 is the dominant COX product of mast cells and is an effector of aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease (AERD). Objective: We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells to generate PGD(2) and facilitate tissue eosinophilia and nasal polyposis in patients with AERD. Methods: Urinary eicosanoid levels were measured in aspirin-tolerant control subjects and patients with AERD. Nasal polyp specimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR, Western blotting, and immunohistochemistry. Human cord blood-and peripheral blood-derived mast cells were stimulated with TSLP in vitro to assess PGD(2) generation. Results: Urinary levels of a stable PGD(2) metabolite (uPGD-M) were 2-fold higher in patients with AERD relative to those in control subjects and increased further during aspirin-induced reactions. Peak uPGD-Mlevels during aspirin reactions correlated with reductions in blood eosinophil counts and lung function and increases in nasal congestion. Mast cells sorted from nasal polyps expressed PGD(2) synthase (hematopoietic PGD(2) synthase) mRNA at higher levels than did eosinophils from the same tissue. Whole nasal polyp TSLP mRNA expression correlated strongly with mRNA encoding hematopoietic PGD(2) synthase (r = .75), the mast cell-specific marker carboxypeptidase A3 (r = .74), and uPGD-M (r=0.74). Levels of the cleaved active form of TSLP were increased in nasal polyps from patients with AERD relative to those in aspirin-tolerant control subjects. Recombinant TSLP induced PGD(2) generation by cultured human mast cells. Conclusions: Our study demonstrates that mast cell-derived PGD(2) is a major effector of type 2 immune responses driven by TSLP and suggests that dysregulation of this innate system contributes significantly to the pathophysiology of AERD.
引用
收藏
页码:1566 / +
页数:16
相关论文
共 50 条
  • [31] Heat Shock Protein 70 Gene Polymorphisms in Japanese Patients With Aspirin-Exacerbated Respiratory Disease
    Kikuchi, Kiyokazu
    Abe, Shyuzo
    Kodaira, Kazumi
    Yukawa, Tatsuo
    Hozawa, Soichiro
    Mochizuki, Hiroyuki
    Kurosawa, Motohiro
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (04) : 708 - 714
  • [32] A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease
    Purevsuren Losol
    Seung-Hyun Kim
    Yoo Seob Shin
    Young Min Ye
    Hae-Sim Park
    Experimental & Molecular Medicine, 2013, 45 : e14 - e14
  • [33] Loss of smell in patients with aspirin-exacerbated respiratory disease impacts mental health and quality of life
    Tchekmedyian, Raffi
    Lundberg, Marie
    Buchheit, Kathleen M.
    Maurer, Rie
    Gakpo, Deborah
    Mullur, Jyotsna
    Bensko, Jillian C.
    Laidlaw, Tanya M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (12) : 1414 - 1421
  • [34] Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease
    Hope, Andrew P.
    Woessner, Katharine A.
    Simon, Ronald A.
    Stevenson, Donald D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : 406 - 410
  • [35] Association of P2RY12 polymorphisms with eosinophil and platelet activation in patients with aspirin-exacerbated respiratory disease
    Losol, Purevsuren
    Palikhe, Nami Shrestha
    Lee, Ji Won
    Palikhe, Sailesh
    Kim, Mi-Ae
    Yang, Eun-Mi
    Choi, Hyunna
    Choi, Gil-Soon
    Kim, Seung-Hyun
    Park, Hae-Sim
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (05) : 423 - +
  • [36] Effect of Zileuton Treatment on Sinonasal Quality of Life in Patients with Aspirin-Exacerbated Respiratory Disease
    Lee, Saangyoung E.
    Farquhar, Douglas R.
    Adams, Katherine N.
    Masood, Maheer M.
    Senior, Brent A.
    Thorp, Brian D.
    Zanation, Adam M.
    Ebert, Charles S., Jr.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2019, 33 (06) : 791 - 795
  • [37] Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin-Exacerbated Respiratory Disease
    Shah, Neelam H.
    Schneider, Thomas R.
    Yeh, Doreen DeFaria
    Cahill, Katherine N.
    Laidlaw, Tanya M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (06) : 1215 - 1219
  • [38] Perioperative management and perceived risks of sinus surgery in patients with aspirin-exacerbated respiratory disease
    Wangberg, Hannah
    Spierling Bagsic, Samantha R.
    Levy, Joshua M.
    White, Andrew
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (07) : 1132 - 1134
  • [39] Nasal Ketorolac Challenge Using Acoustic Rhinometry in Patients With Aspirin-Exacerbated Respiratory Disease
    Quiralte-Castillo, J.
    Avila-Castellano, M. R.
    Cimbollek, S.
    Benaixa, P.
    Leguisamo, S.
    Baynova, K.
    Labella, M.
    Quiralte, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2017, 27 (03) : 169 - 174
  • [40] Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis?
    Kim, Joo-Hee
    Choi, Gil-Soon
    Kim, Jeong-Eun
    Jin, Hyun-Jung
    Ye, Young-Min
    Kim, Seung-Hyun
    Park, Hae-Sim
    PHARMACOGENOMICS, 2014, 15 (04) : 449 - 457